AbbVie (ABBV) Q3 2017 Results - Earnings Call Transcript

Oct. 27, 2017 2:11 PM ETAbbVie Inc. (ABBV)
SA Transcripts profile picture
SA Transcripts

AbbVie, Inc. (NYSE:ABBV) Q3 2017 Earnings Call October 27, 2017 9:00 AM ET


Elizabeth Shea - AbbVie, Inc.

Richard A. Gonzalez - AbbVie, Inc.

Michael E. Severino, M.D. - AbbVie, Inc.

William J. Chase - AbbVie, Inc.


Jeffrey Holford - Jefferies LLC

Jami Rubin - Goldman Sachs & Co. LLC

Joshua Schimmer - Evercore ISI

Christopher Schott - JPMorgan Securities LLC

Evan Seigerman - Barclays Capital, Inc.

Steve Scala - Cowen and Co. LLC

Geoffrey C. Porges - Leerink Partners LLC

Vamil K. Divan - Credit Suisse Securities (USA) LLC

Gregory D. Fraser - Deutsche Bank Securities, Inc.


Good morning and thank you all for holding. Welcome to the AbbVie third quarter 2017 earnings conference call. All participants will be able to listen only until the question-and-answer portion of this call. I would like to remind all parties today's call is being recorded. If you have any objections, please disconnect at this time.

I would now like to introduce Ms. Liz Shea, Vice President of Investor Relations.

Elizabeth Shea - AbbVie, Inc.

Good morning and thank you for joining us. Also on the call with me today are: Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Michael Severino, Executive Vice President of Research & Development and Chief Scientific Officer; and Bill Chase, Executive Vice President of Finance and Chief Financial Officer.

Before we get started, I remind you that some statements that we make today are or may be considered forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Additional information about the factors that may affect AbbVie's operations is included in our 2016 Annual Report on

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.